All Stories

  1. Genetic and enzymatic basis of xylooligosaccharide metabolism by Bifidobacterium longum
  2. Delving into Enzyme-Encoding Genes in Metagenome Assembled Genomes from Artisanal Dairies Producing Raw Ewe Milk PDO Cheeses
  3. Investigating the role of bacterial raw milk community members in chlorate reduction
  4. Metabolic pathway analysis reveals hierarchical pentose sugar utilization and metabolic flexibility of Bifidobacterium longum
  5. Adaptations and Community Changes in Milk and Water Kefir Microbiomes in Response to Environmental Parameters as Revealed by the Kefir4All Project
  6. Investigating the role of bacterial raw milk community members in chlorate reduction
  7. A technical feasibility study evaluating sustainable enzyme‐based cleaning‐in‐place (CIP) for removal of milk deposits formed on stainless steel surfaces during cheesemilk pasteurisation
  8. Exploring the Functional Potential of the Broiler Gut Microbiome Using Shotgun Metagenomics
  9. Breastfeeding and the milk resistome shape the establishment and transmission of antibiotic resistance genes in the infant gut microbiome
  10. Effects of feeding a simulated waste milk on growth, health, fecal microbiota, and antibiotic resistance in dairy heifer calves
  11. Stress and depression risk in pregnancy associates with altered immune function
  12. Investigating the role of bacterial raw milk community members in chlorate reduction
  13. Development of a modular test bed for evaluating sustainable CIP strategies and fouling removal during milk pasteurisation for cheese production
  14. Strain-level variation among vaginal Lactobacillus crispatus and Lactobacillus iners as identified by comparative metagenomics
  15. The core microbiomes and associated metabolic potential of water kefir as revealed by pan multi-omics
  16. Bactofencin A Displays a Delayed Killing Effect on a Clinical Strain of Staphylococcus aureus Which Is Greatly Accelerated in the Presence of Nisin
  17. A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal...
  18. Author Correction: Examining the healthy human microbiome concept
  19. Investigating the Bioactivities of a Dextran and Levan Mixture Produced by the Sourdough-Derived Leuconostoc mesenteroides Strain DSA_F
  20. Gut MicrobiotAware: how much do we know about gut microbiota? An international questionnaire
  21. Bifidobacterium fermentum sp. nov. and Bifidobacterium aquikefiricola sp. nov., isolated from water kefir
  22. Examining the healthy human microbiome concept
  23. Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon
  24. Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications
  25. The changing landscape with respect to scientific research and education for second-level students and how they can overlap: the Kefir4All example
  26. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients
  27. Pseudocin 196, a novel lantibiotic produced by Bifidobacterium pseudocatenulatum elicits antimicrobial activity against clinically relevant pathogens
  28. Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation in Dendritic Cells
  29. Cataloging metagenome-assembled genomes and microbial genes from the athlete gut microbiome
  30. GROND: a quality-checked and publicly available database of full-length 16S-ITS-23S rRNA operon sequences
  31. Comparative Metagenomics of Vaginal Microbiomes Reveal Strain-Level Differences with Relevance to Colonization and Host-Microbe Interactions
  32. Two extracellular α-arabinofuranosidases are required for cereal-derived arabinoxylan metabolism by Bifidobacterium longum subsp. longum
  33. Kefir4All, a citizen science initiative to raise awareness of the roles that microbes play in food fermentation
  34. Novel Fermentates Can Enhance Key Immune Responses Associated with Viral Immunity
  35. Seasonal and geographical impact on the Irish raw milk microbiota correlates with chemical composition and climatic variables
  36. Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation
  37. Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
  38. Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond
  39. Novel Fermentates Can Enhance Key Immune Responses Associated with Viral Immunity
  40. Development of Fluid Handling Capabilities for Autonomous Sampling Capsule
  41. The impact of live dietary microbes on health: A scoping review
  42. Fermented foods and gastrointestinal health: underlying mechanisms
  43. Profiling of vaginal Lactobacillus jensenii isolated from preterm and full-term pregnancies reveals strain-specific factors relating to host interaction
  44. Associations between the postpartum uterine and vaginal microbiota and the subsequent development of purulent vaginal discharge vary with dairy cow breed and parity
  45. Use of reconstituted kefir consortia to determine the impact of microbial composition on kefir metabolite profiles
  46. Analysis of the milk kefir pan-metagenome reveals four community types, core species, and associated metabolic pathways
  47. Microbiome Interconnectedness throughout Environments with Major Consequences for Healthy People and a Healthy Planet
  48. The impact of live dietary microbes on health: a scoping review
  49. Amplicon-Based High-Throughput Sequencing Method for Genotypic Characterization of Norovirus in Oysters
  50. Differences in Faecal Microbiome Taxonomy, Diversity and Functional Potential in a Bovine Cohort Experimentally Challenged with Mycobacterium avium subsp. paratuberculosis (MAP)
  51. Mapping the available evidence on the impact of ingested live microbes on health: a scoping review protocol
  52. Comprehensive insight into the alterations in the gut microbiome and the intestinal barrier as a consequence of iron deficiency anaemia
  53. Comparison of the relative impacts of acute consumption of an inulin-enriched diet, milk kefir or a commercial probiotic product on the human gut microbiome and metabolome
  54. Benchmarking Bioinformatic Tools for Amplicon-Based Sequencing of Norovirus
  55. Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway
  56. Development of an amplicon-based high throughput sequencing method for genotypic characterisation of norovirus in oysters
  57. The Athlete Gut Microbiome and its Relevance to Health and Performance: A Review
  58. Human gut homeostasis and regeneration: the role of the gut microbiota and its metabolites
  59. Arbuscular Mycorrhiza Support Plant Sulfur Supply through Organosulfur Mobilizing Bacteria in the Hypho- and Rhizosphere
  60. Bioinformatic approaches for studying the microbiome of fermented food
  61. Recruiting and Engaging Women of Reproductive Age with Obesity: Insights from A Mixed-Methods Study within A Trial
  62. The Application of Metagenomics to Study Microbial Communities and Develop Desirable Traits in Fermented Foods
  63. FANGORN: A quality-checked and publicly available database of full-length 16S-ITS-23S rRNA operon sequences
  64. Using Shotgun Sequencing to Describe the Changes Induced by In-Feed Zinc Oxide and Apramycin in the Microbiomes of Pigs One Week Postweaning
  65. Use of Probiotic Bacteria and Bacteriocins as an Alternative to Antibiotics in Aquaculture
  66. Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model
  67. A Graph-Based Molecular Communications Model Analysis of the Human Gut Bacteriome
  68. Gut Steroids and Microbiota: Effect of Gonadectomy and Sex
  69. African fermented foods: overview, emerging benefits, and novel approaches to microbiome profiling
  70. An oxidation resistant pediocin PA-1 derivative and penocin A display effective anti- Listeria activity in a model human gut environment
  71. Identification of Gut Bacteria such as Lactobacillus johnsonii that Disseminate to Systemic Tissues of Wild Type and MyD88–/– Mice
  72. Seasonality and Geography Have a Greater Influence than the Use of Chlorine-Based Cleaning Agents on the Microbiota of Bulk Tank Raw Milk
  73. Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions
  74. Recreating pink defect in cheese with different strains of Thermus bacteria
  75. Editorial: Bacteriocins and Other Ribosomally Synthesised and Post-translationally Modified Peptides (RiPPs) as Alternatives to Antibiotics
  76. Depletion of the gut microbiota differentially affects the impact of whey protein on high‐fat diet‐induced obesity and intestinal permeability
  77. MAP, Johne’s disease and the microbiome; current knowledge and future considerations
  78. Protein quality and quantity influence the effect of dietary fat on weight gain and tissue partitioning via host-microbiota changes
  79. Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine
  80. Bio-Engineered Nisin with Increased Anti-Staphylococcus and Selectively Reduced Anti-Lactococcus Activity for Treatment of Bovine Mastitis
  81. Porcine reproductive and respiratory syndrome virus impacts on gut microbiome in a strain virulence‐dependent fashion
  82. Assessing the ability of nisin A and derivatives thereof to inhibit gram-negative bacteria from the genus Thermus
  83. The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study
  84. In vitro–in vivo Validation of Stimulatory Effect of Oat Ingredients on Lactobacilli
  85. Microbiome-based environmental monitoring of a dairy processing facility highlights the challenges associated with low microbial-load samples
  86. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
  87. Comparison of the carotenoid profiles of commonly consumed smear-ripened cheeses
  88. The microbiome of deep-sea fish reveals new microbial species and a sparsity of antibiotic resistance genes
  89. Investigating the Role of Diet and Exercise in Gut Microbe-Host Cometabolism
  90. Fermented-Food Metagenomics Reveals Substrate-Associated Differences in Taxonomy and Health-Associated and Antibiotic Resistance Determinants
  91. Antimicrobial use and production system shape the fecal, environmental, and slurry resistomes of pig farms
  92. Shotgun sequencing of the vaginal microbiome reveals both a species and functional potential signature of preterm birth
  93. Outbreak of acute larval cyathostominosis – A “perfect storm” of inflammation and dysbiosis
  94. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
  95. Gut microbes from the phylogenetically diverse genusEubacteriumand their various contributions to gut health
  96. Meta-analysis of cheese microbiomes highlights contributions to multiple aspects of quality
  97. Kefir microbial composition is a deciding factor in the physiological impact of kefir in a mouse model of obesity
  98. Maternal and infant factors that shape neonatal gut colonization by bacteria
  99. The effects of sustained fitness improvement on the gut microbiome: A longitudinal, repeated measures case-study approach
  100. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome
  101. Tracking the Dairy Microbiota from Farm Bulk Tank to Skimmed Milk Powder
  102. Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL ...
  103. Antifungal Peptides as Therapeutic Agents
  104. Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
  105. The association between the maternal diet and the maternal and infant gut microbiome: a systematic review
  106. Distinct microbiome composition and metabolome exists across subgroups of elite Irish athletes
  107. The impact of probiotic supplementation on metabolic health in healthy women of reproductive age: a systematic review
  108. Metabolic phenotyping of the human microbiome
  109. Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
  110. First evidence of production of the lantibiotic nisin P
  111. Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis
  112. Caprine milk fermentation enhances the antithrombotic properties of cheese polar lipids
  113. The Potential Impact of Probiotics on the Gut Microbiome of Athletes
  114. Improvement of Feed Efficiency in Pigs through Microbial Modulation via Fecal Microbiota Transplantation in Sows and Dietary Supplementation of Inulin in Offspring
  115. Four men in a boat: Ultra-endurance exercise alters the gut microbiome
  116. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
  117. Diversity and composition of the gut microbiota of Atlantic salmon ( Salmo salar ) farmed in Irish waters
  118. Porcine Feed Efficiency-Associated Intestinal Microbiota and Physiological Traits: Finding Consistent Cross-Locational Biomarkers for Residual Feed Intake
  119. Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir
  120. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components
  121. Brevibacillus laterosporus strains BGSP7, BGSP9 and BGSP11 isolated from silage produce broad spectrum multi-antimicrobials
  122. Influence of the Intestinal Microbiota on Colonization Resistance to Salmonella and the Shedding Pattern of Naturally Exposed Pigs
  123. Biofilms in Food Processing Environments: Challenges and Opportunities
  124. The dynamics of the antibiotic resistome in the feces of freshly weaned pigs following therapeutic administration of oxytetracycline
  125. Multiparametric liquid biopsy analysis in metastatic prostate cancer
  126. Dietary α-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice
  127. The effect of ovine milk fermentation on the antithrombotic properties of polar lipids
  128. Lactobacillus gasseri APC 678 Reduces Shedding of the Pathogen Clostridium difficile in a Murine Model
  129. Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial
  130. Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection
  131. Bioengineering Nisin to overcome the Nisin Resistance Protein
  132. Functional Characterization of the Lactolisterin BU Gene Cluster of Lactococcus lactis subsp. lactis BGBU1-4
  133. In silico Prediction and Exploration of Potential Bacteriocin Gene Clusters Within the Bacterial Genus Geobacillus
  134. The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis
  135. The rumen microbiome: a crucial consideration when optimising milk and meat production and nitrogen utilisation efficiency
  136. Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX
  137. The potency of the broad spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation
  138. Mesophilic Sporeformers Identified in Whey Powder by Using Shotgun Metagenomic Sequencing
  139. A Diverse Range of Human Gut Bacteria Have the Potential To Metabolize the Dietary Component Gallic Acid
  140. Heterologous Expression of Biopreservative Bacteriocins With a View to Low Cost Production
  141. Genomic Characterization of Sulphite Reducing Bacteria Isolated From the Dairy Production Chain
  142. Effect of milk centrifugation and incorporation of high heat-treated centrifugate on the microbial composition and levels of volatile organic compounds of Maasdam cheese
  143. Oral Delivery of Nisin in Resistant Starch Based Matrices Alters the Gut Microbiota in Mice
  144. Sequencing of the Cheese Microbiome and Its Relevance to Industry
  145. Early Salmonella Typhimurium infection in pigs disrupts Microbiome composition and functionality principally at the ileum mucosa
  146. A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults
  147. Fighting biofilms with lantibiotics and other groups of bacteriocins
  148. Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis
  149. Gut microbiota as a source of novel antimicrobials
  150. Species classifier choice is a key consideration when analysing low-complexity food microbiome data
  151. Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring
  152. The intestinal protist Blastocystis is not a common member of the healthy infant gut microbiota in a Westernized country (Ireland)
  153. Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis
  154. Novel insights into the microbiology of fermented dairy foods
  155. Omics-Based Insights into Flavor Development and Microbial Succession within Surface-Ripened Cheese
  156. Build the Read: A Hands-On Activity for Introducing Microbiology Students to NGS and Bioinformatics.
  157. Genome Sequence of Geobacillus stearothermophilus DSM 458, an Antimicrobial-Producing Thermophilic Bacterium, Isolated from a Sugar Beet Factory
  158. Plantaricyclin A, a Novel Circular Bacteriocin Produced by Lactobacillus plantarum NI326: Purification, Characterization, and Heterologous Production
  159. Application of bacteriocin-producing Enterococcus faecium isolated from donkey milk, in the bio-control of Listeria monocytogenes in fresh whey cheese
  160. Lack of Heterogeneity in Bacteriocin Production Across a Selection of Commercial Probiotic Products
  161. Metagenome-based surveillance and diagnostic approaches to studying the microbial ecology of food production and processing environments
  162. Bacteriocin with broad spectrum of activity
  163. Crop Establishment Practices Are a Driver of the Plant Microbiota in Winter Oilseed Rape (Brassica napus)
  164. High-throughput metataxonomic characterization of the raw milk microbiota identifies changes reflecting lactation stage and storage conditions
  165. Use of enhanced nisin derivatives in combination with food-grade oils or citric acid to control Cronobacter sakazakii and Escherichia coli O157:H7
  166. The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome
  167. Whole-Genome Shotgun Sequence of Salmonella bongori, First Isolated in Northwestern Italy
  168. Whey protein effects on energy balance link the intestinal mechanisms of energy absorption with adiposity and hypothalamic neuropeptide gene expression
  169. Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
  170. Strain-Level Metagenomic Analysis of the Fermented Dairy Beverage Nunu Highlights Potential Food Safety Risks
  171. Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli
  172. Exploring a Possible Link between the Intestinal Microbiota and Feed Efficiency in Pigs
  173. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles
  174. A Profile Hidden Markov Model to investigate the distribution and frequency of LanB-encoding lantibiotic modification genes in the human oral and gut microbiome
  175. Erratum to: The altered gut microbiota in adults with cystic fibrosis
  176. Insights into the Mode of Action of the Sactibiotic Thuricin CD
  177. Forgotten fungi—the gut mycobiome in human health and disease
  178. Health benefits of fermented foods: microbiota and beyond
  179. Drunk bugs: Chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice
  180. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level
  181. The altered gut microbiota in adults with cystic fibrosis
  182. Translating Omics to Food Microbiology
  183. Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model
  184. Correction for Walsh et al., Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  185. Detection and Enumeration of Spore-Forming Bacteria in Powdered Dairy Products
  186. ‘Microbes in sport’ – The potential role of the gut microbiota in athlete health and performance
  187. Gut microbiota: implications for sports and exercise medicine
  188. Preface to the Fourth Edition
  189. Microbiome Changes During Ripening
  190. Microbiota of Raw Milk and Raw Milk Cheeses
  191. A Bioengineered Nisin Derivative, M21A, in Combination with Food Grade Additives Eradicates Biofilms of Listeria monocytogenes
  192. Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome
  193. Impacts of Seasonal Housing and Teat Preparation on Raw Milk Microbiota: a High-Throughput Sequencing Study
  194. Prevalence and genetic diversity of Blastocystis in family units living in the United States
  195. Bacteriocin production: a relatively unharnessed probiotic trait?
  196. Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation
  197. New Weapons to Fight Old Enemies: Novel Strategies for the (Bio)control of Bacterial Biofilms in the Food Industry
  198. Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  199. The bacteriocin bactofencin A subtly modulates gut microbial populations
  200. Miscanthus biochar promotes growth of spring barley and shifts bacterial community structures including phosphorus and sulfur mobilizing bacteria
  201. Thermus and the Pink Discoloration Defect in Cheese
  202. 16S rRNA gene sequencing of mock microbial populations- impact of DNA extraction method, primer choice and sequencing platform
  203. The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells
  204. Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model
  205. The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
  206. In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms
  207. Bacteriocins: Novel Solutions to Age Old Spore-Related Problems?
  208. Compromised Lactobacillus helveticus starter activity in the presence of facultative heterofermentative Lactobacillus casei DPC6987 results in atypical eye formation in Swiss-type cheese
  209. Comparative Genomic Analysis Reveals a Diverse Repertoire of Genes Involved in Prokaryote-Eukaryote Interactions within the Pseudovibrio Genus
  210. Draft Genome Sequence of Lactobacillus casei DPC6800, an Isolate with the Potential to Diversify Flavor in Cheese
  211. Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis
  212. FoodMicrobionet: A database for the visualisation and exploration of food bacterial communities based on network analysis
  213. Somatic/gonadal mosaicism for structural autosomal rearrangements: female predominance among carriers of gonadal mosaicism for unbalanced rearrangements
  214. A novel method of microsatellite genotyping-by-sequencing using individual combinatorial barcoding
  215. Detection of presumptive Bacillus cereus in the Irish dairy farm environment
  216. Value of Microbial Genome Sequencing for Probiotic Strain Identification and Characterization
  217. The Prevalence and Control of Bacillus and Related Spore-Forming Bacteria in the Dairy Industry
  218. Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57/BL6J mice
  219. Bioengineering Lantibiotics for Therapeutic Success
  220. High-throughput DNA sequencing to survey bacterial histidine and tyrosine decarboxylases in raw milk cheeses
  221. Re: Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  222. Correction: N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  223. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood
  224. Generation of the antimicrobial peptide caseicin A from casein by hydrolysis with thermolysin enzymes
  225. N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  226. In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database
  227. Impact of Environmental Factors on Bacteriocin Promoter Activity in Gut-Derived Lactobacillus salivarius
  228. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  229. Bovine serum albumin as the dominant form of dietary protein reduces subcutaneous fat mass, plasma leptin and plasma corticosterone in high fat-fed C57/BL6J mice
  230. The Sactibiotic Subclass of Bacteriocins: An Update
  231. Biotechnological applications of functional metagenomics in the food and pharmaceutical industries
  232. Bioengineering of the model lantibiotic nisin
  233. Nisin H Is a New Nisin Variant Produced by the Gut-Derived Strain Streptococcus hyointestinalis DPC6484
  234. Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population
  235. Evaluation of Lactococcus lactis Isolates from Nondairy Sources with Potential Dairy Applications Reveals Extensive Phenotype-Genotype Disparity and Implications for a Revised Species
  236. Antimicrobial antagonists against food pathogens: a bacteriocin perspective
  237. The metabolic role of the microbiota
  238. A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
  239. Lantibiotic Resistance
  240. Exercise and the microbiota
  241. Proteomics as the final step in the functional metagenomics study of antimicrobial resistance
  242. Anaerobic sporeformers and their significance with respect to milk and dairy products
  243. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice
  244. Engineered nisin variants control Listeria in food
  245. Temporal and Spatial Differences in Microbial Composition during the Manufacture of a Continental-Type Cheese
  246. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
  247. Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgery
  248. Streptozotocin-induced type-1-diabetes disease onset in Sprague–Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity
  249. Bacteriocin Mining in Metagenomes
  250. Marine Pseudovibrio sp. as a Novel Source of Antimicrobials
  251. The potential for emerging therapeutic options forClostridium difficileinfection
  252. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease
  253. Exopolysaccharide-Producing Probiotic Lactobacilli Reduce Serum Cholesterol and Modify Enteric Microbiota in ApoE-Deficient Mice1,2
  254. Identification of Aminoglycoside and β-Lactam Resistance Genes from within an Infant Gut Functional Metagenomic Library
  255. The microbial eukaryoteBlastocystisis a prevalent and diverse member of the healthy human gut microbiota
  256. Author response: linking lifestyle and microbes
  257. Fermented beverages with health-promoting potential: Past and future perspectives
  258. Exercise and associated dietary extremes impact on gut microbial diversity
  259. An ‘Upp'-turn in bacteriocin receptor identification
  260. Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate
  261. Heterologous Expression of Thuricin CD Immunity Genes in Listeria monocytogenes
  262. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples
  263. Beneficial modulation of the gut microbiota
  264. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice
  265. Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice
  266. A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota
  267. Atypical Listeria innocua strains possess an intact LIPI-3
  268. Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method
  269. In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Resistance to Aminoglycosides but Not to Β-Lactams
  270. Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
  271. Interactions between gut microbiota, food and the obese host
  272. Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
  273. Sequence-Based Analysis of the Intestinal Microbiota of Sows and Their Offspring Fed Genetically Modified Maize Expressing a Truncated Form of Bacillus thuringiensis Cry1Ab Protein (Bt Maize)
  274. Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride
  275. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
  276. Sequence-based analysis of the microbial composition of water kefir from multiple sources
  277. The complex microbiota of raw milk
  278. The microbial content of raw and pasteurized cow milk as determined by molecular approaches
  279. Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources
  280. Bacteriocin production by Bifidobacterium spp. A review
  281. Bacterial Communities Established in Bauxite Residues with Different Restoration Histories
  282. Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge
  283. Subtilomycin: A New Lantibiotic from Bacillus subtilis Strain MMA7 Isolated from the Marine Sponge Haliclona simulans
  284. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome
  285. Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations
  286. Strategies to improve the bacteriocin protection provided by lactic acid bacteria
  287. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
  288. Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
  289. Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
  290. Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants
  291. Microbial Composition of Human Appendices from Patients following Appendectomy
  292. The individual-specific and diverse nature of the preterm infant microbiota
  293. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
  294. Additions and corrections
  295. Antimicrobials
  296. In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice
  297. Microbial production of bacteriocins for use in foods
  298. Nucleic acid-based approaches to investigate microbial-related cheese quality defects
  299. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
  300. Bacteriocin Mining in Metagenomes
  301. Bacteriocins — a viable alternative to antibiotics?
  302. Bioengineering
  303. Assessment of the Bacteriocinogenic Potential of Marine Bacteria Reveals Lichenicidin Production by Seaweed-Derived Bacillus spp.
  304. Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
  305. Lantibiotic Production by Pathogenic Microorganisms
  306. High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
  307. Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI
  308. High-Throughput Sequencing for Detection of Subpopulations of Bacteria Not Previously Associated with Artisanal Cheeses
  309. Supernumerary marker chromosomes derived from chromosome 6: Cytogenetic, molecular cytogenetic, and array CGH characterization
  310. The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota
  311. Lacticin 3147 - Biosynthesis, Molecular Analysis, Immunity, Bioengineering and Applications
  312. Composition of the early intestinal microbiota
  313. The gut microbiota and its relationship to diet and obesity
  314. Impact of leucine on energy balance
  315. A comparison of methods used to extract bacterial DNA from raw milk and raw milk cheese
  316. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota
  317. High-Throughput Sequence-Based Analysis of the Intestinal Microbiota of Weanling Pigs Fed Genetically Modified MON810 Maize Expressing Bacillus thuringiensis Cry1Ab (Bt Maize) for 31 Days
  318. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria
  319. Cronobacter spp. in Powdered Infant Formula
  320. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity
  321. Assessing the Contributions of the LiaS Histidine Kinase to the Innate Resistance of Listeria monocytogenes to Nisin, Cephalosporins, and Disinfectants
  322. Technological characterization of bacteriocin producing Lactococcus lactis strains employed to control Listeria monocytogenes in Cottage cheese
  323. Bioengineered nisin derivatives with enhanced activity in complex matrices
  324. Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change
  325. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
  326. Antimicrobial Peptides as Therapeutic Agents
  327. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
  328. The Lantibiotic Lacticin 3147 Prevents Systemic Spread ofStaphylococcus aureusin a Murine Infection Model
  329. Homologues and Bioengineered Derivatives of LtnJ Vary in Ability to Form D-Alanine in the Lantibiotic Lacticin 3147
  330. ThespiFEGLocus in Streptococcus infantarius subsp. infantarius BAA-102 Confers Protection against Nisin U
  331. Molecular approaches to analysing the microbial composition of raw milk and raw milk cheese
  332. Bacteriocin Production: a Probiotic Trait?
  333. Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva
  334. Production of Multiple Bacteriocins from a Single Locus by Gastrointestinal Strains of Lactobacillus salivarius
  335. Flagging flora: help from bacteriocins?
  336. Streptolysin S-like virulence factors: the continuing sagA
  337. Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters
  338. High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain
  339. An International Network for Improving Health Properties of Food by Sharing our Knowledge on the Digestive Process
  340. Bacteriocins as Natural Antilisterial Food Preservatives
  341. The impact of nisin on sensitive and resistant mutants of Listeria monocytogenes in cottage cheese
  342. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract
  343. Small intestine and microbiota
  344. Further Identification of Novel Lantibiotic Operons Using LanM-Based Genome Mining
  345. Altering the Composition of Caseicins A and B as a Means of Determining the Contribution of Specific Residues to Antimicrobial Activity
  346. Real-Time PCR Assay To Differentiate Listeriolysin S-Positive and -Negative Strains ofListeria monocytogenes
  347. The gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs
  348. The dawning of a ‘Golden era’ in lantibiotic bioengineering
  349. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
  350. Effect of Bioengineering Lacticin 3147 Lanthionine Bridges on Specific Activity and Resistance to Heat and Proteases
  351. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
  352. Investigating the importance of charged residues in lantibiotics
  353. TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting Antibiotics
  354. Glutamate Decarboxylase-Mediated Nisin Resistance in Listeria monocytogenes
  355. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria
  356. The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various β-Lactam Antibiotics
  357. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
  358. Synthesis of Trypsin-Resistant Variants of the Listeria-Active Bacteriocin Salivaricin P
  359. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
  360. In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
  361. Production of the Bsa Lantibiotic by Community-Acquired Staphylococcus aureus Strains
  362. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147
  363. Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM Proteins
  364. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
  365. Discovery of Medically Significant Lantibiotics
  366. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147
  367. Isolation and Analysis of Bacteria with Antimicrobial Activities from the Marine Sponge Haliclona simulans Collected from Irish Waters
  368. Listeriolysin S, a Novel Peptide Haemolysin Associated with a Subset of Lineage I Listeria monocytogenes
  369. The generation of nisin variants with enhanced activity against specific Gram-positive pathogens
  370. Controlling Listeria monocytogenes in Cottage cheese through heterologous production of enterocin A by Lactococcus lactis
  371. Lantibiotic Immunity
  372. Two-Peptide Lantibiotics: A Medical Perspective
  373. A System for the Random Mutagenesis of the Two-Peptide Lantibiotic Lacticin 3147: Analysis of Mutants Producing Reduced Antibacterial Activities
  374. The glutamate decarboxylase acid resistance mechanism affects survival of Listeria monocytogenes LO28 in modified atmosphere-packaged foods
  375. Insertional Mutagenesis To Generate Lantibiotic Resistance in Lactococcus lactis
  376. Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphileBacillus haloduransC-125
  377. Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
  378. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design
  379. Bacteriocins: Biological tools for bio-preservation and shelf-life extension
  380. Contribution of Penicillin-Binding Protein Homologs to Antibiotic Resistance, Cell Morphology, and Virulence of Listeria monocytogenes EGDe
  381. Spontaneous resistance inLactococcus lactisIL1403 to the lantibiotic lacticin 3147
  382. Overproduction of Wild-Type and Bioengineered Derivatives of the Lantibiotic Lacticin 3147
  383. Posttranslational conversion of l -serines to d -alanines is vital for optimal production and activity of the lantibiotic lacticin 3147
  384. Food Microbiology: Bacteriocins: developing innate immunity for food
  385. Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations
  386. Presence of GadD1 Glutamate Decarboxylase in Selected Listeria monocytogenes Strains Is Associated with an Ability To Grow at Low pH
  387. Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food
  388. Bacterial Lantibiotics: Strategies to Improve Therapeutic Potential
  389. Structural Characterization of Lacticin 3147, a Two-Peptide Lantibiotic with Synergistic Activity†
  390. Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
  391. A Food-Grade Approach for Functional Analysis and Modification of Native Plasmids in Lactococcus lactis
  392. The LisRK Signal Transduction System Determines the Sensitivity of Listeria monocytogenes to Nisin and Cephalosporins
  393. Bacterial stress response in Listeria monocytogenes: jumping the hurdles imposed by minimal processing
  394. Role of the Glutamate Decarboxylase Acid Resistance System in the Survival of Listeria monocytogenes LO28 in Low pH Foods
  395. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid
  396. Analysis of the role of the Listeria monocytogenes F0F1-ATPase operon in the acid tolerance response
  397. Applications of Lactic Acid Bacteria-Produced Bacteriocins